Back to CITIGROUP INC CITIGROUP INC

ABUSABUS
Showing 8 of 11 quarters

Position history for CITIGROUP INCCITIGROUP INC's holdings in ARBUTUS BIOPHARMA CORP

Yes. Citigroup holds 879,237 shares of ABUS (Arbutus Biopharma), worth $4.2M, as of its Q2 2026 13F filing. It reduced the position by 19,184 shares (-2.1%) from Q1 2026. Citigroup has held ABUS in every 13F on record since Q4 2023, 11 quarterly filings.

Current Value

$4.2M

Current Shares

879,237

Total Value Change

+$3.8M

Total Shares Change

+770,186

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
879,237
-2.1%
$4.2M0.0%$4.80
0
2026-Q1
Increased
898,421
+47.0%
$4M0.0%$4.50
37
2025-Q4
Increased
611,149
+208.9%
$2.9M0.0%$4.81
42
2025-Q3
Decreased
197,838
-13.9%
$898,1840.0%$4.54
0
2025-Q2
Decreased
229,814
-12.2%
$710,1260.0%$3.09
0
2025-Q1
Increased
261,836
+39.5%
$913,8080.0%$3.49
33
2024-Q4
Increased
187,720
+72.1%
$613,8440.0%$3.27
36
2024-Q3
Decreased
109,051
-90.5%
$419,8460.0%$3.85
0

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used